Loading...
Loading...
Morgan Stanley raised its price target on Albemarle Corporation
ALB to $59 from $52, and is keeping its Overweight rating.
In a note to clients, Morgan Stanley writes, "Driven by exceptional pricing power, combined with some modest volume growth, we believe Albemarle is set to earn EPS of $4.41 in 2011, some 8% above the company's 2012 target of $4.10. Trading on a 2011e P/E of 11.1x (an 18% discount to peers), the stock appears materially undervalued, despite having one of the best long-term outlooks in the in the US Chemicals sector."
Shares of ALB closed at $50.07 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in